March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Detection Of Proliferative Diabetic Retinopathy: A Comparison Of Ultra-Widefield With Conventional Fluorescein Angiography
Author Affiliations & Notes
  • Gregory W. Oldham
    Ophthalmology, Krieger Eye Institute, Sinai Hospital of Baltimore, Baltimore, Maryland
  • Philip Scharper
    Ophthalmology, Krieger Eye Institute, Sinai Hospital of Baltimore, Baltimore, Maryland
  • Footnotes
    Commercial Relationships  Gregory W. Oldham, None; Philip Scharper, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2073. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gregory W. Oldham, Philip Scharper; Detection Of Proliferative Diabetic Retinopathy: A Comparison Of Ultra-Widefield With Conventional Fluorescein Angiography. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2073.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

Diabetic retinopathy affects both the peripheral and central retina, but conventional digital fluorescein angiography only captures 500 of the posterior pole compared to 2000 with a scanning laser ophthalmoscope. Peripheral proliferative diabetic retinopathy may therefore go undiagnosed with the use of conventional imaging, and thwart the opportunity for early intervention. We retrospectively evaluated whether there is a differing degree of peripheral neovascular disease detected in diabetic patients with ultra-widefield (Optos 200TX) fluorescein angiography (FA), versus conventional FA (Zeiss FF 450 plus IR fundus camera) with peripheral mapping techniques.

 
Methods:
 

Angiographic features of 15 eyes of 14 diabetic patients were examined by a single retina specialist. All patients had presumed nonproliferative diabetic retinopathy, and were presenting for routine exam. Angiography was conducted on one visit with a single trained technician; first, standard FA (Zeiss FF 450 plus IR fundus camera) with a single dye injection, followed by immediate ultra-widefield (Optos 200TX) angiography. A seven-field montage was created from the standard FA, and compared to one widefield image. Angiograms were individually graded for the amount of neovascularization utilizing a standardized mapping system with a calibrated grid placed on the images. The number of grid sectors with angiographic evidence of retinal neovascularization within each image was recorded. Main outcome measurements were the total number of grid sectors with neovascularization, and the number of patients with neovascular disease found with ultra-widefield alone.

 
Results:
 

For ultra-widefield FA with the Optos 200TX, the mean number of grid sectors with retinal neovascular disease was 1.9 ± 1.7, versus 0.73 ± 1.09 grid sectors with the seven-field montage. Peripheral retinal neovascularization was evident on ultra-widefield imaging in 4 of 15 eyes (26.7%) that was not visible with conventional FA.

 
Conclusions:
 

Ultra-widefield FA with the Optos 200TX is a superior testing modality for the evaluation of peripheral neovascular disease in diabetic patients compared to conventional seven-field imaging. Greater recognition of peripheral angiographic disease could allow for earlier treatment intervention and consequently prevent blinding complications of diabetic retinopathy.

 
Keywords: imaging/image analysis: clinical • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • retinal neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×